Quipt Home Medical Corp

Quipt Home Medical Corp. engages in the provision of in-home monitoring and disease management services including end-to-end respiratory solutions. Its services include sleep apnea and pap treatment, home ventilation, equipment solutions, daily and ambulatory aides, power mobility, respiratory equipment rental, and oxygen therapy. The company was founded on March 5, 1993 and is headquartered in Wilder, KY.

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Quipt Home Medical Corp. engages in the provision of in-home monitoring and disease management services including end-to-end respiratory solutions. Its services include sleep apnea and pap treatment, home ventilation, equipment solutions, daily and ambulatory aides, power mobility, respiratory equipment rental, and oxygen therapy. The company was founded on March 5, 1997 and is headquartered in Wilder, KY.

Quipt Home Medical's recurring revenue model and strong gross margins provide stability, despite recent setbacks and a 50% stock drop this year. Operational challenges, including Medicare policy changes and a cyberattack, have impacted revenue and profitability, contributing to the stock's decline. The company has a solid growth plan focused on organic expansion and acquisitions, aiming for 8%-10% growth in FY2025.

Struggling For Air: Quipt Home Medical's Growth Hurdles And Recovery Potential

Quipt Home Medical Corp. (NASDAQ:QIPT ) Q4 2024 Earnings Conference Call December 17, 2024 10:00 AM ET Company Participants Greg Crawford - Chairman & Chief Executive Officer Hardik Mehta - Chief Financial Officer Conference Call Participants Richard Close - Canaccord Genuity Bill Sutherland - The Benchmark Company Julian Hung - Stifel Doug Cooper - Beacon Securities Operator Thank you for standing by. This is the conference operator.

Quipt Home Medical Corp. (QIPT) Q4 2024 Earnings Call Transcript

Quipt Home Medical Corp. (QIPT) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of $0.01. This compares to loss of $0.03 per share a year ago.

Quipt Home Medical Corp. (QIPT) Reports Q4 Loss, Misses Revenue Estimates

Posts Strong Adjusted EBITDA Margin‎ 1 ‎for Fiscal Year 2024 and Returns to Positive Sequential Growth in Fiscal Q4 2024

Quipt Home Medical Reports Fourth Quarter and Fiscal Year 2024 Financial Results

CINCINNATI, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the “Company”) (NASDAQ: QIPT) (TSX: QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, will announce its fiscal fourth quarter and full year 2024 financial results on Monday, December 16, 2024, after market close. Gregory Crawford, Chief Executive Officer, and Hardik Mehta, Chief Financial Officer, will host a conference call for the investment community on Tuesday, December 17, 2024, at 10:00 a.m. (ET).

Quipt Home Medical Corp. to Announce Fiscal Fourth Quarter and Full Year 2024 Financial Results on December 16, 2024

Value investing principles from Benjamin Graham emphasize buying undervalued stocks based on arithmetic, not optimism, especially in a record high market. Quipt is significantly undervalued with a $256 million revenue run rate and a $122 million market cap. The aging U.S. population and a large undiagnosed market for sleep apnea create a strong growth potential for Quipt.

Quipt Home Medical: Deep Value With Explosive Upside

Quipt Home Medical Corp. (NASDAQ:QIPT ) Q3 2024 Results Conference Call August 15, 2024 10:00 AM ET Company Participants Greg Crawford - Chairman, CEO Hardik Mehta - CFO Conference Call Participants Richard Close - Canaccord Genuity Justin Keywood - Stifel Stefan Quenneville - Venton Financial Operator Thank you for standing by. This is the conference operator.

Quipt Home Medical Corp. (QIPT) Q3 2024 Earnings Call Transcript

Quipt Home Medical Corp. (QIPT) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of $0.01. This compares to loss of $0.03 per share a year ago.

Quipt Home Medical Corp. (QIPT) Reports Q3 Loss, Lags Revenue Estimates

CINCINNATI, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the “Company”) (NASDAQ: QIPT; TSX: QIPT), a U.S.-based home medical equipment provider, focused on end-to-end respiratory care, today announced its third quarter fiscal 2024 financial results and operational highlights. These results pertain to the three and nine months ended June 30, 2024, and are reported in United States dollars ("$", "dollars" and "US$") and have been rounded to the nearest hundred thousand.

Quipt Home Medical Reports Third Quarter Fiscal 2024 Financial Results

Quipt Home Medical (QIPT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Quipt Home Medical Corp. (QIPT) Reports Next Week: Wall Street Expects Earnings Growth

CINCINNATI, July 31, 2024 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the “Company”) (NASDAQ: QIPT) (TSX: QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, will announce its fiscal third quarter 2024 financial results on Wednesday, August 14, 2024, after market close. Gregory Crawford, Chief Executive Officer, and Hardik Mehta, Chief Financial Officer, will host a conference call for the investment community on Thursday, August 15, 2024, at 10:00 a.m. (ET).

Quipt Home Medical Corp. to Announce Fiscal Third Quarter 2024 Financial Results on August 14, 2024

Quipt Home Medical Corp. (NASDAQ:QIPT ) Q2 2024 Earnings Conference Call May 16, 2024 10:00 AM ET Company Participants Greg Crawford - Chairman, CEO Hardik Mehta - CFO Conference Call Participants Richard Close - Canaccord Genuity Douglas Cooper - Beacon Securities Justin Keywood - Stifel Bill Sutherland - The Benchmark Company Rahul Sarugaser - Raymond James Operator Thank you for standing by. This is the conference operator.

Quipt Home Medical Corp. (QIPT) Q2 2024 Earnings Call Transcript

• Posts Adjusted EBITDA Margin of 23.3% as a % of Revenue • Announced Normal Course Issuer Bid (“NCIB”) Subsequent to Quarter End CINCINNATI, May 15, 2024 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the “Company”) (NASDAQ: QIPT; TSX: QIPT), a U.S.-based home medical equipment provider, focused on end-to-end respiratory care, today announced its second quarter fiscal 2024 financial results and operational highlights. These results pertain to the three and six months ended March 31, 2024, and are reported in United States dollars ("$", "dollars" and "US$") and have been rounded to the nearest hundred thousand.

Quipt Home Medical Reports Second Quarter Fiscal 2024 Financial Results Posting Revenue Growth of 10% and Adjusted EBITDA Growth of 14%

CINCINNATI, Ohio, May 09, 2024 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the “Company”) (NASDAQ: QIPT; TSX: QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, has filed and obtained a receipt for its final short form base shelf prospectus (the “Final Shelf Prospectus”) with the securities commissions in each of the provinces and territories of Canada, and a corresponding Amendment No. 2 to the Registration Statement on Form F-10 (File No. 333-276253) previously filed by the Company with the United States ‎Securities and Exchange Commission (the “SEC”) on December 22, 2023 (the “Amended Registration Statement”), with the SEC under the U.S./Canada Multijurisdictional Disclosure System‎. The Final Shelf Prospectus and corresponding Amended Registration Statement enable the Company to offer up to C$300,000,000 of common shares, preferred shares, debt securities, warrants to acquire any of the securities that are described in the Final Shelf Prospectus‎, subscription receipts, and units comprised of any one or more of any of the other securities that are described in the Final Shelf Prospectus‎, or any combination thereof (collectively, the “Securities”) at any time during the 25-month period that the Final Shelf Prospectus remains effective.

Quipt Home Medical Corp. Announces Filing of Final Base Shelf Prospectus

CINCINNATI, May 06, 2024 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the “Company”) (NASDAQ: QIPT) (TSX: QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, will announce its fiscal second quarter 2024 financial results on Wednesday, May 15, 2024. Gregory Crawford, Chief Executive Officer, and Hardik Mehta, Chief Financial Officer, will host a conference call for the investment community on Thursday, May 16, 2024, at 10:00 a.m. (ET).

Quipt Home Medical Corp. to Announce Fiscal Second Quarter 2024 Financial Results on May 15, 2024

CINCINNATI, May 02, 2024 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the “Company”) (NASDAQ: QIPT) (TSX: QIPT)‎, a U.S. based home medical equipment provider, focused on end-to-end respiratory care, announced today that the Toronto Stock Exchange (“TSX”) has accepted the Company's notice of intention to implement a normal course issuer bid (the “NCIB”).

Quipt Home Medical Announces Normal Course Issuer Bid

CINCINNATI, March 28, 2024 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the “Company”) (NASDAQ: QIPT) (TSX: QIPT)‎, a U.S. based home medical equipment provider, focused on end-to-end respiratory care, today announced the voting results from its annual general and special meeting of shareholders held on March 27, 2024 (the “Meeting”) in Wilder, Kentucky. The total number of shares represented in person or by proxy at the Meeting was 25,432,699, representing 60.4% of the total issued and outstanding shares in the capital of the Company.

Quipt Home Medical Announces Voting Results from Its Annual General and Special Meeting of Shareholders

Quipt Home Medical is capturing strong demand for its portfolio of at-home care respiratory medical equipment and related services. Despite volatile earnings, the company's latest quarterly report showed improving margins and a path for accelerating profitability. We are bullish on the stock, which appears undervalued and supported by solid fundamentals.

Quipt Home Medical Stock: Strong Demand For Respiratory Care Can Lift Shares Higher

CINCINNATI, March 12, 2024 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the “Company”) (NASDAQ: QIPT) (TSX: QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, today announced the Company is scheduled to participate in the 36th Annual Roth Conference to be held in Laguna Niguel, California, on March 17-19, 2024.

Quipt Home Medical Announces Participation in the 36th Annual Roth Investor Conference on March 17-19, 2024

Quipt Home Medical Corp. (QIPT) Q1 2024 Earnings Call Transcript

Quipt Home Medical Corp. (QIPT) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to earnings of $0.01 per share a year ago.

Quipt Home Medical Corp. (QIPT) Reports Q1 Loss, Tops Revenue Estimates

Posts Adjusted EBITDA Margin of 23.5% and 2% Sequential Organic Growth Posts Adjusted EBITDA Margin of 23.5% and 2% Sequential Organic Growth

Quipt Home Medical Reports Strong Operating Performance With Record First Quarter Fiscal 2024 Financial Results Posting Revenue Growth of 60% and Adjusted EBITDA Growth of 71%

Quipt Home Medical Corp. (QIPT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Quipt Home Medical Corp. (QIPT) Expected to Beat Earnings Estimates: Should You Buy?

CINCINNATI, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the “Company”) (NASDAQ: QIPT) (TSX: QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, will announce its fiscal first quarter 2024 financial results on Wednesday, February 14, 2024. Gregory Crawford, Chief Executive Officer, and Hardik Mehta, Chief Financial Officer, will host a conference call for the investment community on Thursday, February 15, 2024, at 10:00 a.m. (ET).

Quipt Home Medical Corp. to Announce Fiscal First Quarter 2024 Financial Results on February 14, 2024

Amazon

Booking Hlds

Medtronic

UiPath

Raytheon Technologies

The market is flying as we enter 2024, but some sectors offer compelling values. Other stocks will be terrific buys when they return to Earth.

News for Quipt Home Medical Corp Stock (QIPT)